Piedmont Cancer Institute — Atlanta, Georgia

Piedmont Cancer Institute is a clinical research site located in Atlanta, Georgia, United States 30309.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Piedmont Cancer Institute has participated in 27 clinical trials with 11 currently active.

Therapeutic areas: Triple Negative Breast Neoplasms, Breast Cancer, Non-Small Cell Lung Cancer.

Sponsors: Seagen Inc., Puma Biotechnology, Inc., Calithera Biosciences, Inc.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Piedmont Cancer Institute?

Piedmont Cancer Institute has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Piedmont Cancer Institute conducted?

Piedmont Cancer Institute has 27 clinical trials on record, with 11 currently active. Their work covers Triple Negative Breast Neoplasms, Breast Cancer, Non-Small Cell Lung Cancer.

Is Piedmont Cancer Institute accredited by Crixeo Health?

Yes — Piedmont Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Piedmont Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.